Literature DB >> 21653644

Risk of primary non-breast cancer after female breast cancer by age at diagnosis.

Lene Mellemkjær1, Jane Christensen, Kirsten Frederiksen, Eero Pukkala, Elisabete Weiderpass, Freddie Bray, Søren Friis, Michael Andersson, Jørgen H Olsen.   

Abstract

BACKGROUND: Women diagnosed with breast cancer at young age have been shown to be at higher risk of developing a new primary cancer than women diagnosed at older ages, but little is known about whether adjustment for calendar year of breast cancer diagnosis, length of follow-up, and/or breast cancer treatment alters the risk pattern by age.
METHODS: We identified 304,703 women diagnosed with breast cancer during 1943 to 2006 in the Cancer Registries of Denmark, Norway, and Finland. Relative risks (RR) of subsequent non-breast cancer by age at cancer diagnosis were calculated using Poisson regression models adjusted for country, calendar period, length of follow-up, and treatment. Excess absolute risks (EAR) were also calculated.
RESULTS: The RR for all cancer sites except breast cancer decreased with increasing age both with and without adjustments. The RR and the EAR differed for each age at diagnosis category until the women reached their late 70s. Many specific cancer forms contributed to the overall risk pattern by age with endometrial cancer as 1 exception.
CONCLUSIONS: The age at breast cancer diagnosis is an essential risk factor for being diagnosed with a new primary non-breast cancer and the level of risk for specific ages at diagnosis may hold for many years after the diagnosis. Occurrence of endometrial cancer after breast cancer seems to follow a distinct age pattern different from that seen for most other cancer types. IMPACT: Future studies should aim at exploring the underlying explanations for the age-related findings. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21653644     DOI: 10.1158/1055-9965.EPI-11-0009

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

Review 1.  The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis.

Authors:  Sarah M Nielsen; Michael G White; Susan Hong; Briseis Aschebrook-Kilfoy; Edwin L Kaplan; Peter Angelos; Swati A Kulkarni; Olufunmilayo I Olopade; Raymon H Grogan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

2.  Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.

Authors:  Giovanna Masci; Michele Caruso; Francesco Caruso; Piermario Salvini; Carlo Carnaghi; Laura Giordano; Vittoria Miserocchi; Agnese Losurdo; Monica Zuradelli; Rosalba Torrisi; Luca Di Tommaso; Corrado Tinterri; Alberto Testori; Carlos A Garcia-Etienne; Wolfgang Gatzemeier; Armando Santoro
Journal:  Oncologist       Date:  2015-05-06

3.  Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment.

Authors:  Gabriella Ferrandina; Giulia Amadio; Andrea Marcellusi; Elena Azzolini; Anna Puggina; Roberta Pastorino; Walter Ricciardi; Giovanni Scambia
Journal:  Clin Drug Investig       Date:  2017-11       Impact factor: 2.859

4.  Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study.

Authors:  Man-Hsin Hung; Chia-Jen Liu; Chung-Jen Teng; Yu-Wen Hu; Chiu-Mei Yeh; San-Chi Chen; Sheng-Hsuan Chien; Yi-Ping Hung; Cheng-Che Shen; Tzeng-Ji Chen; Cheng-Hwai Tzeng; Chun-Yu Liu
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

5.  The clinicopathological features of second primary cancer in patients with prior breast cancer.

Authors:  YiHui Liu; ChunHui Dong; Ling Chen
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

6.  Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers.

Authors:  Janghee Lee; Seho Park; Sanghwa Kim; Jeeye Kim; Jegyu Ryu; Hyung Seok Park; Seung Il Kim; Byeong-Woo Park
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

7.  Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort.

Authors:  Marina Kvaskoff; Anne Bijon; Sylvie Mesrine; Alice Vilier; Laura Baglietto; Agnès Fournier; Françoise Clavel-Chapelon; Laure Dossus; Marie-Christine Boutron-Ruault
Journal:  PLoS Med       Date:  2014-06-10       Impact factor: 11.069

8.  Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study.

Authors:  Raffaella Marcheselli; Luigi Marcheselli; Laura Cortesi; Alessia Bari; Claudia Cirilli; Samantha Pozzi; Paola Ferri; Martina Napolitano; Massimo Federico; Stefano Sacchi
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

9.  Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018.

Authors:  Jenny Nyqvist; Toshima Z Parris; Khalil Helou; Elisabeth Kenne Sarenmalm; Zakaria Einbeigi; Per Karlsson; Salmir Nasic; Anikó Kovács
Journal:  Breast Cancer Res Treat       Date:  2020-08-01       Impact factor: 4.872

10.  Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors.

Authors:  Beth A Glenn; Narissa J Nonzee; Ann S Hamilton; Lina Tieu; Annette E Maxwell; Catherine M Crespi; L Cindy Chang; Dennis Deapen; Roshan Bastani
Journal:  J Cancer Surviv       Date:  2020-08-14       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.